Venturing into drug discovery.

被引：0

作者：

Steinmetz M. ^{[1
]}

机构：

[1] MPM Asset Management, Cambridge

来源：

关键词：

D O I：

10.1038/5401

中图分类号：

学科分类号：

摘要：

[No abstract available]

引用

页码：17 / 17

共 50 条

[1] Industrialization of drug discovery.
Handen, JS
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U472 - U472
[2] Pharmacophores in drug discovery.
Milne, GWA
Wang, SM
Nicklaus, MC
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1997, 214 : 47 - CINF
[3] Glycosylation in drug discovery.
Ichikawa, Y
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U262 - U262
[4] Genomic approaches to drug discovery.
Golub, Todd
CLINICAL CANCER RESEARCH, 2018, 24 (02) : 19 - 19
[5] Natural products in drug discovery.
Danishefsky, SJ
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U364 - U365
[6] Genomics and CNS drug discovery.
Paul, SM
AMERICAN JOURNAL OF MEDICAL GENETICS, 1997, 74 (06): : 604 - 605
[7] In silico ADME in drug discovery.
Penzotti, JE
Grootenhuis, PDJ
Labute, P
Srinivasan, J
Rourick, RA
Kassel, DB
Jenkins, KM
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 222 : U273 - U273
[8] Molecular modelling in drug discovery.
Cornell, W
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U27 - U27
[9] Metabolomic profiles in drug discovery.
Beecher, C
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 228 : U164 - U165
[10] Impact of biotechnology on drug discovery.
Drews, J
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 219 : U168 - U168